Reactivated endogenous retroviruses promote protein aggregate spreading.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
18 08 2023
Historique:
received: 21 06 2022
accepted: 02 08 2023
medline: 21 8 2023
pubmed: 19 8 2023
entrez: 18 8 2023
Statut: epublish

Résumé

Prion-like spreading of protein misfolding is a characteristic of neurodegenerative diseases, but the exact mechanisms of intercellular protein aggregate dissemination remain unresolved. Evidence accumulates that endogenous retroviruses, remnants of viral germline infections that are normally epigenetically silenced, become upregulated in neurodegenerative diseases such as amyotrophic lateral sclerosis and tauopathies. Here we uncover that activation of endogenous retroviruses affects prion-like spreading of proteopathic seeds. We show that upregulation of endogenous retroviruses drastically increases the dissemination of protein aggregates between cells in culture, a process that can be inhibited by targeting the viral envelope protein or viral protein processing. Human endogenous retrovirus envelopes of four different clades also elevate intercellular spreading of proteopathic seeds, including pathological Tau. Our data support a role of endogenous retroviruses in protein misfolding diseases and suggest that antiviral drugs could represent promising candidates for inhibiting protein aggregate spreading.

Identifiants

pubmed: 37596282
doi: 10.1038/s41467-023-40632-z
pii: 10.1038/s41467-023-40632-z
pmc: PMC10439213
doi:

Substances chimiques

Protein Aggregates 0
Antiviral Agents 0
Prions 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5034

Informations de copyright

© 2023. Springer Nature Limited.

Références

Nat Cell Biol. 2009 Jul;11(7):909-13
pubmed: 19503072
FASEB J. 2014 Aug;28(8):3703-19
pubmed: 24812088
J Virol Methods. 2004 Dec 15;122(2):131-9
pubmed: 15542136
Hum Gene Ther. 2019 Dec;30(12):1477-1493
pubmed: 31578886
EMBO J. 2006 Jun 21;25(12):2674-85
pubmed: 16724107
PLoS Genet. 2007 Oct;3(10):2014-22
pubmed: 17967065
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552
pubmed: 34723319
Trends Mol Med. 2018 Apr;24(4):379-394
pubmed: 29551251
Nat Neurosci. 2014 Mar;17(3):357-66
pubmed: 24464041
Neuron. 2016 Nov 23;92(4):796-812
pubmed: 27974162
Brain. 2016 Dec;139(Pt 12):3187-3201
pubmed: 27679482
Front Neurosci. 2018 Jul 19;12:487
pubmed: 30072868
J Virol. 1974 Jul;14(1):152-61
pubmed: 4134468
Virology. 2011 Mar 15;411(2):273-87
pubmed: 21251689
J Virol. 1987 Jun;61(6):2059-62
pubmed: 2883329
Sci Transl Med. 2015 Sep 30;7(307):307ra153
pubmed: 26424568
Cell Rep. 2018 Jun 5;23(10):2874-2880
pubmed: 29874575
Brain Res. 2012 Jun 26;1462:61-80
pubmed: 22445064
PLoS One. 2012;7(1):e30872
pubmed: 22295118
Int J Cancer. 1998 May 4;76(3):430-6
pubmed: 9579583
J Virol. 1975 Oct;16(4):844-53
pubmed: 170419
Nucleic Acids Res. 1994 Mar 25;22(6):1101-7
pubmed: 8152913
JCI Insight. 2020 Apr 9;5(7):
pubmed: 32271161
J Clin Virol. 2010 Feb;47(2):136-42
pubmed: 20005155
J Virol. 2019 Sep 30;93(20):
pubmed: 31341050
J Virol. 1994 Mar;68(3):1773-81
pubmed: 8107239
Mol Neurodegener. 2011 Jun 23;6(1):44
pubmed: 21699683
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
J Immunol. 2007 Jul 15;179(2):1210-24
pubmed: 17617614
Ann Neurol. 2022 Oct;92(4):545-561
pubmed: 35801347
J Virol. 2007 Sep;81(17):9437-42
pubmed: 17581995
J Immunol. 2014 Feb 15;192(4):1343-9
pubmed: 24511094
J Virol. 2004 Feb;78(3):1411-20
pubmed: 14722296
Nat Neurosci. 2018 Aug;21(8):1038-1048
pubmed: 30038280
Biol Chem. 2006 Aug;387(8):1113-20
pubmed: 16895482
J Gen Virol. 1984 May;65 ( Pt 5):887-98
pubmed: 6202829
Viruses. 2015 Mar 04;7(3):939-68
pubmed: 25746218
Retrovirology. 2010 Nov 30;7:101
pubmed: 21118532
J Virol. 2017 Oct 13;91(21):
pubmed: 28794032
Oncoimmunology. 2015 Dec 29;5(5):e1122160
pubmed: 27467919
Cancer Immunol Res. 2018 Nov;6(11):1292-1300
pubmed: 30143537
Nat Rev Microbiol. 2005 Aug;3(8):643-55
pubmed: 16064056
Nature. 2012 Nov 29;491(7426):774-8
pubmed: 23103862
Sci Rep. 2019 Nov 27;9(1):17637
pubmed: 31776415
Front Neurosci. 2021 Sep 01;15:724891
pubmed: 34539339
J Virol. 2013 Sep;87(17):9845-55
pubmed: 23824809
Eur J Neurol. 2018 Aug;25(8):1076-e84
pubmed: 29603839
J Gen Virol. 2019 Apr;100(4):662-668
pubmed: 30794119
J Gen Virol. 2006 May;87(Pt 5):1321-1330
pubmed: 16603535
Nat Commun. 2021 Jul 9;12(1):4231
pubmed: 34244499
Nat Commun. 2021 Oct 19;12(1):5739
pubmed: 34667166
J Virol. 2013 Feb;87(3):1518-27
pubmed: 23152533
Virol Sin. 2021 Oct;36(5):1006-1026
pubmed: 33770381
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8187-E8196
pubmed: 27911827
Virology. 2016 Jan;487:121-8
pubmed: 26517399
Nat Neurosci. 2004 Oct;7(10):1088-95
pubmed: 15452578
Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):25982-25990
pubmed: 31792184
Commun Med (Lond). 2021;1:
pubmed: 35083468
Viruses. 2014 Dec 26;7(1):1-26
pubmed: 25549291
J Virol. 1999 Feb;73(2):1460-7
pubmed: 9882352
J Virol. 2002 Jul;76(13):6442-52
pubmed: 12050356
mBio. 2016 Jul 12;7(4):
pubmed: 27406566
Cell Mol Life Sci. 2020 May;77(9):1721-1744
pubmed: 31667556
Retrovirology. 2011 Nov 08;8:90
pubmed: 22067224
J Virol. 1990 Dec;64(12):6176-83
pubmed: 1700832
Sci Transl Med. 2020 Jan 1;12(524):
pubmed: 31894103
J Immunol. 2009 Jun 15;182(12):8094-103
pubmed: 19494335
Int J Mol Sci. 2022 Mar 22;23(7):
pubmed: 35408821
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
pubmed: 11309499
PLoS Genet. 2006 Jan;2(1):e2
pubmed: 16440055
Ann Neurol. 2011 Jan;69(1):141-51
pubmed: 21280084
Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):462-7
pubmed: 19114662
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
Int J Cancer. 2006 Aug 15;119(4):815-22
pubmed: 16550601
Amyotroph Lateral Scler Frontotemporal Degener. 2022 Feb;23(1-2):100-107
pubmed: 34151656
Front Neurosci. 2021 Mar 12;15:648629
pubmed: 33776642
Int J Cancer. 1973 May;11(3):616-27
pubmed: 4133949
J Virol. 2009 Dec;83(24):12790-800
pubmed: 19812154
Anal Chem. 2003 Feb 1;75(3):663-70
pubmed: 12585499
Biochemistry (Mosc). 2017 Aug;82(8):962-971
pubmed: 28941465
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):5951-6
pubmed: 23509289
J Virol. 2000 Apr;74(7):3321-9
pubmed: 10708449
Biol Cell. 2008 Oct;100(10):603-15
pubmed: 18422484

Auteurs

Shu Liu (S)

German Center for Neurodegenerative Diseases Bonn (DZNE), Venusberg Campus 1/ 99, 53127, Bonn, Germany.
German Federal Institute for Risk Assessment (BfR), German Centre for the Protection of Laboratory Animals (Bf3R), Max-Dohrn-Straße 8-10, 10589, Berlin, Germany.

Stefanie-Elisabeth Heumüller (SE)

German Center for Neurodegenerative Diseases Bonn (DZNE), Venusberg Campus 1/ 99, 53127, Bonn, Germany.

André Hossinger (A)

German Center for Neurodegenerative Diseases Bonn (DZNE), Venusberg Campus 1/ 99, 53127, Bonn, Germany.

Stephan A Müller (SA)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

Oleksandra Buravlova (O)

German Center for Neurodegenerative Diseases Bonn (DZNE), Venusberg Campus 1/ 99, 53127, Bonn, Germany.

Stefan F Lichtenthaler (SF)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, 81675, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Philip Denner (P)

German Center for Neurodegenerative Diseases Bonn (DZNE), Venusberg Campus 1/ 99, 53127, Bonn, Germany.

Ina M Vorberg (IM)

German Center for Neurodegenerative Diseases Bonn (DZNE), Venusberg Campus 1/ 99, 53127, Bonn, Germany. ina.vorberg@dzne.de.
Department of Neurology, Rheinische Friedrich-Wilhelms-Universität Bonn, Germany, Venusberg-Campus 1, 53127, Bonn, Germany. ina.vorberg@dzne.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH